Back to Search
JOHN HUBERTY, M.D.
M.D.
Gynecology Physician
NPI: 1568441608Individual
Specialties, Licenses & Credentials
Gynecology PhysicianPrimary
Obstetrics & Gynecology — Gynecology
Code: 207VG0400X
MD00012432(WA)
Research & Publications (14)
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
PMID 19636009·J Clin Oncol·2009
3-trial
After-school program impact on physical activity and fitness: a meta-analysis.
PMID 19362799·Am J Prev Med·2009
1-meta
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
PMID 19171714·J Clin Oncol·2009
3-trial
Women Bound to Be Active: a pilot study to explore the feasibility of an intervention to increase physical activity and self-worth in women.
PMID 18843841·Women Health·2008
8-other
Explaining long-term exercise adherence in women who complete a structured exercise program.
PMID 18816949·Res Q Exerc Sport·2008
8-other
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.
PMID 18682939·Eur J Nucl Med Mol Imaging·2008
3-trial
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
PMID 17369569·J Clin Oncol·2007
3-trial
Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
PMID 17102115·Ann N Y Acad Sci·2006
3-trial
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
PMID 15490487·Pediatr Blood Cancer·2005
8-other
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
PMID 15197208·J Clin Oncol·2004
3-trial
High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
PMID 12872341·Cancer·2003
8-other
Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma.
PMID 12847321·J Pediatr Hematol Oncol·2003
5-case
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
PMID 11696644·J Nucl Med·2001
3-trial
Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG.
PMID 11216522·J Nucl Med·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1205 SE PROFESSIONAL MALL BLVD, STE 102
PULLMAN, WA 99163 - Phone
- (509) 332-7511
Quick Facts
- NPI
- 1568441608
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile